Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure

Cardiac involvement in systemic amyloidosis (AL) occurs in ~50% of all AL patients. However once symptomatic heart failure develops, therapeutic options are limited thereby conferring a poor overall prognosis. The median survival is <6 months when AL patients are untreated for the underlying plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahir, Usman A., Doros, Gheorghe, Kim, John S., Connors, Lawreen H., Seldin, David C., Sam, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561903/
https://www.ncbi.nlm.nih.gov/pubmed/31189919
http://dx.doi.org/10.1038/s41598-019-44912-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561903/
https://www.ncbi.nlm.nih.gov/pubmed/31189919
http://dx.doi.org/10.1038/s41598-019-44912-x

Ejemplares similares